Circulating endothelial cell (CEC) and tumor cell (CTC) analysis in patients (pts) receiving bevacizumab and erlotinib for metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Rugo, H. S.; Dickler, M. N.; Scott, J. H.; Moore, D. H.; Park, J. W. |
| Abstract Title: | Circulating endothelial cell (CEC) and tumor cell (CTC) analysis in patients (pts) receiving bevacizumab and erlotinib for metastatic breast cancer (MBC) |
| Meeting Title: | 27th Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Breast Cancer Research and Treatment |
| Volume: | 88 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2004 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0167-6806 |
| Publisher: | Springer |
| Date Published: | 2004-01-01 |
| Start Page: | S142 |
| End Page: | S143 |
| Language: | English |
| ACCESSION: | WOS:000225589600402 |
| PROVIDER: | wos |
| PUBMED: | 15612103 |
| DOI: | 10.1007/s10549-004-3602-z |
| Notes: | Meeting Abstract: 3088 -- 27th Annual Charles A Colman San Antonio Breast Cancer Symposium -- DEC 08-11, 2004 -- San Antonio, TX -- 1 -- Source: Wos |
